|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000179144 |
Summary for GIMAP7 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000179144 | Gene symbol | GIMAP7 |
| Gene name | GTPase, IMAP family member 7 | |
| HGNC | 22404 | |
| Entrez ID | 168537 | |
| Gene type | protein_coding | |
| Synonyms | GIMAP7|MGC27027|IAN7 | |
| UniProtAcc | Q8NHV1 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for GIMAP7 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| GIMAP7 | 3.69e+02 | -1.01e+00 | 4.03e-01 | -2.50e+00 | 1.24e-02 | 4.44e-02 | ESCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| GIMAP7 | 7.81e+02 | -1.01e+00 | 2.49e-01 | -4.04e+00 | 5.28e-05 | 1.48e-04 | KICH |
| GIMAP7 | 8.23e+02 | -1.41e+00 | 1.09e-01 | -1.29e+01 | 3.60e-38 | 2.46e-37 | BRCA |
| GIMAP7 | 1.85e+02 | -1.79e+00 | 3.53e-01 | -5.07e+00 | 3.96e-07 | 3.93e-06 | READ |
Top |
Sex-biased somatic mutation for GIMAP7 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for GIMAP7 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg08037327 | chr7:150513973 | CGI:chr7:150407616-150408442 | promoter | 8.14e-01 | 6.72e-01 | 2.13e+00 | 3.33e-02 | 4.28e-02 | 1.41e-01 |
| BRCA | cg01827098 | chr7:150514064 | CGI:chr7:150407616-150408442 | promoter | 7.65e-01 | 6.27e-01 | 2.48e+00 | 1.32e-02 | 2.97e-02 | 1.38e-01 |
| MESO | cg15849098 | chr7:150514673 | CGI:chr7:150407616-150408442 | promoter | 7.18e-01 | 5.95e-01 | 2.09e+00 | 3.68e-02 | 4.68e-02 | 1.24e-01 |
| MESO | cg24413842 | chr7:150514732 | CGI:chr7:150407616-150408442 | promoter | 6.18e-01 | 4.83e-01 | 2.55e+00 | 1.06e-02 | 2.92e-02 | 1.34e-01 |
| MESO | cg17643598 | chr7:150514767 | CGI:chr7:150407616-150408442 | promoter | 3.92e-01 | 2.56e-01 | 2.95e+00 | 3.14e-03 | 1.31e-02 | 1.36e-01 |
| MESO | cg07956751 | chr7:150514851 | CGI:chr7:150407616-150408442 | UTR,promoter,exon,gene body | 4.74e-01 | 3.60e-01 | 2.25e+00 | 2.46e-02 | 4.16e-02 | 1.13e-01 |
| ACC | cg00051483 | chr7:150514723 | CGI:chr7:150407616-150408442 | promoter | 3.51e-01 | 2.27e-01 | 2.63e+00 | 8.52e-03 | 2.34e-02 | 1.24e-01 |
| ACC | cg15704358 | chr7:150513892 | CGI:chr7:150407616-150408442 | promoter | 8.84e-01 | 7.46e-01 | 3.07e+00 | 2.12e-03 | 9.55e-03 | 1.38e-01 |
| ACC | cg24413842 | chr7:150514732 | CGI:chr7:150407616-150408442 | promoter | 5.67e-01 | 4.50e-01 | 2.03e+00 | 4.25e-02 | 4.68e-02 | 1.18e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUAD | cg01827098 | chr7:150514064 | CGI:chr7:150407616-150408442 | promoter | 6.97e-01 | 8.41e-01 | -3.30e+00 | 9.59e-04 | 1.87e-03 | -1.44e-01 |
| LUAD | cg00051483 | chr7:150514723 | CGI:chr7:150407616-150408442 | promoter | 2.40e-01 | 3.62e-01 | -4.07e+00 | 4.67e-05 | 1.49e-04 | -1.22e-01 |
| LUAD | cg17643598 | chr7:150514767 | CGI:chr7:150407616-150408442 | promoter | 2.10e-01 | 3.19e-01 | -4.11e+00 | 3.91e-05 | 1.29e-04 | -1.09e-01 |
| LUSC | cg01827098 | chr7:150514064 | CGI:chr7:150407616-150408442 | promoter | 7.22e-01 | 8.38e-01 | -2.38e+00 | 1.74e-02 | 2.13e-02 | -1.17e-01 |
| BLCA | cg15704358 | chr7:150513892 | CGI:chr7:150407616-150408442 | promoter | 8.60e-01 | 9.71e-01 | -2.65e+00 | 7.95e-03 | 1.18e-02 | -1.11e-01 |
| BLCA | cg15849098 | chr7:150514673 | CGI:chr7:150407616-150408442 | promoter | 5.40e-01 | 7.40e-01 | -2.43e+00 | 1.49e-02 | 1.94e-02 | -2.00e-01 |
| BLCA | cg24413842 | chr7:150514732 | CGI:chr7:150407616-150408442 | promoter | 2.52e-01 | 4.27e-01 | -3.31e+00 | 9.33e-04 | 2.15e-03 | -1.75e-01 |
| BLCA | cg17643598 | chr7:150514767 | CGI:chr7:150407616-150408442 | promoter | 1.56e-01 | 3.43e-01 | -3.87e+00 | 1.11e-04 | 4.31e-04 | -1.88e-01 |
| BLCA | cg07956751 | chr7:150514851 | CGI:chr7:150407616-150408442 | UTR,promoter,exon,gene body | 2.35e-01 | 3.68e-01 | -2.63e+00 | 8.58e-03 | 1.25e-02 | -1.33e-01 |
| BLCA | cg08637514 | chr7:150515619 | CGI:chr7:150407616-150408442 | promoter,gene body | 3.94e-01 | 7.08e-01 | -2.69e+00 | 7.11e-03 | 1.08e-02 | -3.14e-01 |
| BLCA | cg03801183 | chr7:150515785 | CGI:chr7:150407616-150408442 | promoter,gene body | 2.90e-01 | 5.33e-01 | -3.30e+00 | 9.58e-04 | 2.20e-03 | -2.42e-01 |
| LIHC | cg01827098 | chr7:150514064 | CGI:chr7:150407616-150408442 | promoter | 7.17e-01 | 8.74e-01 | -2.62e+00 | 8.92e-03 | 1.10e-02 | -1.57e-01 |
| ESCA | cg08637514 | chr7:150515619 | CGI:chr7:150407616-150408442 | promoter,gene body | 5.83e-01 | 8.05e-01 | -2.09e+00 | 3.62e-02 | 4.56e-02 | -2.22e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg01827098 | chr7:150514064 | CGI:chr7:150407616-150408442 | promoter | 7.65e-01 | 8.88e-01 | -6.61e+00 | 3.87e-11 | 1.05e-10 | -1.23e-01 |
| BRCA | cg00051483 | chr7:150514723 | CGI:chr7:150407616-150408442 | promoter | 3.52e-01 | 4.56e-01 | -5.79e+00 | 7.04e-09 | 1.59e-08 | -1.04e-01 |
| BRCA | cg24413842 | chr7:150514732 | CGI:chr7:150407616-150408442 | promoter | 4.80e-01 | 5.85e-01 | -5.15e+00 | 2.54e-07 | 5.00e-07 | -1.05e-01 |
| BRCA | cg17643598 | chr7:150514767 | CGI:chr7:150407616-150408442 | promoter | 3.94e-01 | 5.32e-01 | -6.28e+00 | 3.29e-10 | 8.31e-10 | -1.38e-01 |
| BRCA | cg08637514 | chr7:150515619 | CGI:chr7:150407616-150408442 | promoter,gene body | 6.14e-01 | 7.51e-01 | -3.36e+00 | 7.84e-04 | 1.04e-03 | -1.37e-01 |
| LUAD | cg03801183 | chr7:150515785 | CGI:chr7:150407616-150408442 | promoter,gene body | 3.00e-01 | 4.16e-01 | -2.17e+00 | 3.02e-02 | 3.47e-02 | -1.16e-01 |
Top |
Exon skipping events with PSI in TCGA for GIMAP7 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for GIMAP7 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for GIMAP7 |
| TFs related to GIMAP7. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | KLF15 | GIMAP7 | 4.13e+00 | 9.87e-01 | 3.09e+00 | 3.60e-03 | Male-biased |
| ACC | MAZ | GIMAP7 | 4.13e+00 | 9.84e-01 | 3.23e+00 | 6.35e-03 | Male-biased |
| ACC | PLAG1 | GIMAP7 | 4.93e+00 | 9.93e-01 | 3.90e+00 | 3.83e-03 | Male-biased |
| ACC | RREB1 | GIMAP7 | 4.70e+00 | 9.85e-01 | 3.93e+00 | 1.12e-02 | Male-biased |
| ACC | VEZF1 | GIMAP7 | 4.35e+00 | 9.89e-01 | 3.39e+00 | 4.98e-03 | Male-biased |
| ACC | WT1 | GIMAP7 | 3.94e+00 | 9.83e-01 | 2.94e+00 | 4.07e-03 | Male-biased |
| ACC | ZIM2 | GIMAP7 | 4.54e+00 | 9.94e-01 | 3.31e+00 | 1.62e-03 | Male-biased |
| ACC | ZNF263 | GIMAP7 | 4.51e+00 | 9.87e-01 | 3.66e+00 | 8.24e-03 | Male-biased |
| ACC | ZNF333 | GIMAP7 | 5.37e+00 | 9.80e-01 | 4.70e+00 | 1.82e-02 | Male-biased |
| ACC | ZNF334 | GIMAP7 | 4.32e+00 | 5.68e-03 | 5.30e+00 | 9.93e-01 | Female-biased |
| ACC | ZNF415 | GIMAP7 | 5.01e+00 | 9.90e-01 | 4.16e+00 | 7.98e-03 | Male-biased |
| ACC | ZNF432 | GIMAP7 | 4.64e+00 | 9.90e-01 | 3.69e+00 | 5.39e-03 | Male-biased |
| ACC | ZNF467 | GIMAP7 | 4.43e+00 | 9.90e-01 | 3.44e+00 | 4.53e-03 | Male-biased |
| ACC | ZNF529 | GIMAP7 | 4.46e+00 | 9.93e-01 | 3.15e+00 | 1.21e-03 | Male-biased |
| ACC | ZNF793 | GIMAP7 | 5.37e+00 | 9.84e-01 | 4.66e+00 | 1.45e-02 | Male-biased |
| ACC | ZNF816 | GIMAP7 | 5.02e+00 | 9.93e-01 | 4.02e+00 | 4.42e-03 | Male-biased |
| ACC | ZNF880 | GIMAP7 | 4.65e+00 | 9.89e-01 | 3.75e+00 | 6.57e-03 | Male-biased |
| BRCA | HOXA1 | GIMAP7 | 5.23e+00 | 1.86e-02 | 6.26e+00 | 9.81e-01 | Female-biased |
| CHOL | BARX2 | GIMAP7 | 6.46e+00 | 9.88e-01 | 5.52e+00 | 1.18e-02 | Male-biased |
| CHOL | KLF15 | GIMAP7 | 3.22e+00 | 5.25e-03 | 4.31e+00 | 9.87e-01 | Female-biased |
| CHOL | MAZ | GIMAP7 | 3.41e+00 | 5.54e-03 | 4.49e+00 | 9.89e-01 | Female-biased |
| CHOL | VEZF1 | GIMAP7 | 3.56e+00 | 6.12e-03 | 4.61e+00 | 9.89e-01 | Female-biased |
| CHOL | WT1 | GIMAP7 | 3.20e+00 | 6.71e-03 | 4.23e+00 | 9.84e-01 | Female-biased |
| CHOL | ZNF334 | GIMAP7 | 5.41e+00 | 9.86e-01 | 4.49e+00 | 1.25e-02 | Male-biased |
| CHOL | ZNF432 | GIMAP7 | 3.76e+00 | 8.27e-03 | 4.74e+00 | 9.88e-01 | Female-biased |
| CHOL | ZNF467 | GIMAP7 | 3.60e+00 | 8.05e-03 | 4.59e+00 | 9.87e-01 | Female-biased |
| CHOL | ZNF529 | GIMAP7 | 3.61e+00 | 1.33e-02 | 4.47e+00 | 9.81e-01 | Female-biased |
| CHOL | ZNF770 | GIMAP7 | 2.65e+00 | 9.37e-05 | 4.62e+00 | 9.95e-01 | Female-biased |
| CHOL | ZNF85 | GIMAP7 | 6.03e+00 | 9.88e-01 | 5.07e+00 | 1.11e-02 | Male-biased |
| MESO | ZNF334 | GIMAP7 | 6.16e+00 | 1.17e-02 | 7.40e+00 | 9.88e-01 | Female-biased |
| READ | PLAG1 | GIMAP7 | 4.18e+00 | 9.81e-01 | 3.20e+00 | 4.93e-03 | Male-biased |
| READ | ZNF333 | GIMAP7 | 4.47e+00 | 9.87e-01 | 3.48e+00 | 4.87e-03 | Male-biased |
| READ | ZNF334 | GIMAP7 | 6.02e+00 | 9.90e-03 | 6.86e+00 | 9.90e-01 | Female-biased |
| READ | ZNF415 | GIMAP7 | 4.34e+00 | 9.81e-01 | 3.48e+00 | 8.19e-03 | Male-biased |
| READ | ZNF793 | GIMAP7 | 4.74e+00 | 9.89e-01 | 3.79e+00 | 6.06e-03 | Male-biased |
| READ | ZNF816 | GIMAP7 | 4.23e+00 | 9.80e-01 | 3.35e+00 | 7.30e-03 | Male-biased |
| SARC | BARX2 | GIMAP7 | 5.37e+00 | 8.49e-03 | 6.05e+00 | 9.91e-01 | Female-biased |
| SARC | HOXA1 | GIMAP7 | 5.53e+00 | 8.22e-03 | 6.22e+00 | 9.91e-01 | Female-biased |
| SARC | KLF15 | GIMAP7 | 3.96e+00 | 9.80e-01 | 3.17e+00 | 2.41e-03 | Male-biased |
| SARC | MAZ | GIMAP7 | 4.09e+00 | 9.85e-01 | 3.16e+00 | 1.11e-03 | Male-biased |
| SARC | VEZF1 | GIMAP7 | 4.15e+00 | 9.84e-01 | 3.42e+00 | 3.47e-03 | Male-biased |
| SARC | ZNF263 | GIMAP7 | 4.28e+00 | 9.83e-01 | 3.67e+00 | 7.06e-03 | Male-biased |
| SARC | ZNF285 | GIMAP7 | 5.98e+00 | 1.86e-02 | 6.51e+00 | 9.81e-01 | Female-biased |
| SARC | ZNF334 | GIMAP7 | 3.96e+00 | 2.95e-03 | 4.83e+00 | 9.93e-01 | Female-biased |
| SARC | ZNF432 | GIMAP7 | 4.28e+00 | 9.85e-01 | 3.59e+00 | 4.57e-03 | Male-biased |
| SARC | ZNF467 | GIMAP7 | 4.19e+00 | 9.85e-01 | 3.43e+00 | 2.94e-03 | Male-biased |
| SARC | ZNF485 | GIMAP7 | 5.26e+00 | 9.20e-03 | 5.92e+00 | 9.90e-01 | Female-biased |
| SARC | ZNF705G | GIMAP7 | 5.39e+00 | 1.38e-02 | 5.97e+00 | 9.85e-01 | Female-biased |
| SARC | ZNF770 | GIMAP7 | 4.05e+00 | 9.85e-01 | 2.76e+00 | 1.58e-04 | Male-biased |
| SARC | ZNF85 | GIMAP7 | 5.00e+00 | 5.69e-03 | 5.75e+00 | 9.93e-01 | Female-biased |
| SKCM | ZNF334 | GIMAP7 | 6.34e+00 | 6.60e-03 | 7.47e+00 | 9.93e-01 | Female-biased |
| THYM | BARX2 | GIMAP7 | 5.52e+00 | 9.07e-04 | 6.82e+00 | 9.99e-01 | Female-biased |
| THYM | PLAG1 | GIMAP7 | 4.86e+00 | 9.93e-01 | 3.88e+00 | 2.86e-03 | Male-biased |
| THYM | ZIM2 | GIMAP7 | 4.29e+00 | 9.81e-01 | 3.58e+00 | 8.46e-03 | Male-biased |
| THYM | ZNF285 | GIMAP7 | 6.09e+00 | 1.54e-02 | 6.68e+00 | 9.84e-01 | Female-biased |
| THYM | ZNF333 | GIMAP7 | 5.16e+00 | 9.93e-01 | 4.30e+00 | 4.65e-03 | Male-biased |
| THYM | ZNF334 | GIMAP7 | 4.45e+00 | 5.78e-05 | 6.48e+00 | 9.99e-01 | Female-biased |
| THYM | ZNF415 | GIMAP7 | 4.96e+00 | 9.91e-01 | 4.13e+00 | 5.20e-03 | Male-biased |
| THYM | ZNF705G | GIMAP7 | 5.43e+00 | 9.05e-03 | 6.15e+00 | 9.90e-01 | Female-biased |
| THYM | ZNF793 | GIMAP7 | 5.30e+00 | 9.93e-01 | 4.44e+00 | 4.60e-03 | Male-biased |
| THYM | ZNF816 | GIMAP7 | 4.62e+00 | 9.85e-01 | 3.92e+00 | 8.93e-03 | Male-biased |
| THYM | ZNF85 | GIMAP7 | 5.07e+00 | 1.16e-03 | 6.30e+00 | 9.98e-01 | Female-biased |
| GIMAP7 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for GIMAP7 |
| RBPs related to ES in GIMAP7. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| GIMAP7 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs73170628 | chr7:142834589:T:C | - | 0.178837358381483 | 0.0130963526606044 | GBM | Female-baised eQTL |
| rs12537777 | chr7:142839179:G:A | - | 0.178837358381483 | 0.0130963526606044 | GBM | Female-baised eQTL |
| rs56221145 | chr7:142843514:C:A | - | 0.178837358381483 | 0.0130963526606044 | GBM | Female-baised eQTL |
| rs12532577 | chr7:142846083:G:A | - | 0.178837358381483 | 0.0130963526606044 | GBM | Female-baised eQTL |
| rs12536165 | chr7:142847409:G:C | - | 0.178837358381483 | 0.0130963526606044 | GBM | Female-baised eQTL |
| rs6965724 | chr7:155089279:C:T | - | 0.141646744063021 | 0.000603308983860456 | LIHC | Female-baised eQTL |
| rs113921172 | chr7:155087973:T:G | - | 0.113645951510332 | 0.0105563364147315 | LIHC | Female-baised eQTL |
| rs9328526 | chr7:155066345:G:A | - | 0.103880662949973 | 0.0220346451725986 | LIHC | Female-baised eQTL |
| rs58155529 | chr7:155058245:T:C | - | 0.103862335041636 | 0.022104385710565 | LIHC | Female-baised eQTL |
| rs60339077 | chr7:155060766:G:A | - | 0.103862335041636 | 0.022104385710565 | LIHC | Female-baised eQTL |
| rs10231541 | chr7:155062760:C:T | - | 0.103862335041636 | 0.022104385710565 | LIHC | Female-baised eQTL |
| rs10231654 | chr7:155062848:C:T | - | 0.103862335041636 | 0.022104385710565 | LIHC | Female-baised eQTL |
| rs76497466 | chr7:156435795:C:T | - | 0.196338638413755 | 0.0223223468174165 | LIHC | Female-baised eQTL |
| rs6974884 | chr7:155056642:A:G | - | 0.103683081090058 | 0.0229131739367303 | LIHC | Female-baised eQTL |
| rs73729508 | chr7:155059613:C:G | - | 0.103683081090058 | 0.0229131739367303 | LIHC | Female-baised eQTL |
| rs144073742 | chr7:156423219:A:T | - | 0.186121397734248 | 0.0473067642868004 | LIHC | Female-baised eQTL |
| rs144352774 | chr7:142723968:T:C | - | 0.229780828489017 | 0.00797259238576908 | LUSC | Female-baised eQTL |
| rs17163638 | chr7:142718507:C:T | - | 0.213127077466587 | 0.0161444648557174 | LUSC | Female-baised eQTL |
| rs12673576 | chr7:142710192:T:C | - | 0.197840123458439 | 0.031163193202855 | LUSC | Female-baised eQTL |
| rs62470635 | chr7:142718946:C:T | - | 0.197010042187199 | 0.0327293119349654 | LUSC | Female-baised eQTL |
| rs4726572 | chr7:142717016:C:A | - | 0.19690913677594 | 0.0331964236919184 | LUSC | Female-baised eQTL |
| rs2109301 | chr7:157805235:G:C | - | 0.164992643919385 | 0.0368297025524006 | BLCA | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs34516120 | chr7:153301721:T:C | - | 0.162156329800438 | 0.00982795374991242 | SARC | Male-baised eQTL |
| rs58633727 | chr7:153302683:T:C | - | 0.159609612563816 | 0.0126348490532193 | SARC | Male-baised eQTL |
| rs73487064 | chr7:153303161:G:A | - | 0.156215158003346 | 0.0150191947932072 | SARC | Male-baised eQTL |
| rs13237973 | chr7:153303855:A:G | - | 0.156215158003346 | 0.0150191947932072 | SARC | Male-baised eQTL |
| rs13223265 | chr7:153324578:C:G | - | 0.148091981445054 | 0.0329501715103549 | SARC | Male-baised eQTL |
| rs35771452 | chr7:153325383:G:A | - | 0.148091981445054 | 0.0329501715103549 | SARC | Male-baised eQTL |
| rs9640325 | chr7:153306523:A:G | - | 0.137837710161102 | 0.0403989970988562 | SARC | Male-baised eQTL |
| rs7805395 | chr7:156932549:C:T | - | 0.0788579105405432 | 0.0305570271601358 | COAD | Male-baised eQTL |
| rs17478096 | chr7:145985034:G:T | - | 0.0808950246382443 | 0.031999959764079 | COAD | Male-baised eQTL |
| rs34554035 | chr7:145996039:G:A | - | 0.08098589182978 | 0.0353344687188617 | COAD | Male-baised eQTL |
| rs4383898 | chr7:145966624:T:A | - | 0.0733646937382296 | 0.0375409550240018 | COAD | Male-baised eQTL |
| rs62503381 | chr7:145967043:C:T | - | 0.0733646937382296 | 0.0375409550240018 | COAD | Male-baised eQTL |
| rs73160631 | chr7:146011013:T:A | - | 0.0784862626815036 | 0.0452373227006331 | COAD | Male-baised eQTL |
| rs62503439 | chr7:146012389:C:T | - | 0.0784862626815036 | 0.0452373227006331 | COAD | Male-baised eQTL |
| rs36201055 | chr7:146014629:C:T | - | 0.0784862626815036 | 0.0452373227006331 | COAD | Male-baised eQTL |
| rs148029779 | chr7:146017613:G:A | - | 0.0784862626815036 | 0.0452373227006331 | COAD | Male-baised eQTL |
| rs141347470 | chr7:146018688:C:A | - | 0.0784862626815036 | 0.0452373227006331 | COAD | Male-baised eQTL |
| rs62503430 | chr7:145995515:T:A | - | 0.0715354578044118 | 0.0465572984842176 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of GIMAP7 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
